Publications by authors named "Selim Kuci"

Claim this Profile
C
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease.
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Selim Kuci, Zyrafete Kuci

J Transl Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?
Zyrafete Kuçi, Natascha Piede, Kathrin Vogelsang, Lisa-Marie Pfeffermann, Sibylle Wehner

J Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Selim Kuci, Zyrafete Kuci

J Transl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel

Cells· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on β-TCP Scaffold and Show Increased Ability for Osteogenic Differentiation.
Liudmila Leppik, Anna Gempp, Zyrafete Kuçi, Selim Kuçi, Peter Bader

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
Richard Schäfer, Gabriele Spohn, Marco Bechtel, Denisa Bojkova, Patrick C Baer

Stem Cell Reports· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, Shahrzad Bakhtiar, Oliver Basu

Cells· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use.
Karen Bieback, Selim Kuçi, Richard Schäfer

Transfusion· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular signature of human bone marrow-derived mesenchymal stromal cell subsets.
Selim Kuçi, Zyrafete Kuçi, Richard Schäfer, Gabriele Spohn, Stefan Winter

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease.
Sümeyye Elgaz, Zyrafete Kuçi, Selim Kuçi, Halvard Bönig, Peter Bader

Transfus Med Hemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
Cristina Trento, Maria Ester Bernardo, Arnon Nagler, Selim Kuçi, Martin Bornhäuser

Biol Blood Marrow Transplant· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, Oliver Basu, Gesine Bug

Bone Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
Zyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg, Milica Bunos, Anna Jauch

Haematologica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133-Positive Hematopoietic Stem Cells: From Biology to Medicine.
Rupert Handgretinger, Selim Kuçi

Adv Exp Med Biol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells.
Hatixhe Latifi-Pupovci, Zyrafete Kuçi, Sibylle Wehner, Halvard Bönig, Ralf Lieberz

J Transl Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.
Eva Rettinger, Andreas Glatthaar, Behnaz Ahangarian Abhari, Sarah Oelsner, Verena Pfirrmann

Front Pediatr· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.
Eva Rettinger, Hermann Kreyenberg, Michael Merker, Selim Kuçi, Andre Willasch

Cytotherapy· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.
Zyrafete Kuçi, Julia Seiberth, Hatixhe Latifi-Pupovci, Sibylle Wehner, Stefan Stein

Haematologica· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology.
Patrick C Baer, Selim Kuçi, Michael Krause, Zyrafete Kuçi, Stefan Zielen

Stem Cells Dev· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside.
Selim Kuçi, Reinhard Henschler, Ingo Müller, Ettore Biagi, Roland Meisel

Stem Cells Int· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.
Eva Rettinger, Vida Meyer, Hermann Kreyenberg, Andreas Volk, Selim Kuçi

Front Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Eva Rettinger, Selim Kuçi, Ivonne Naumann, Petra Becker, Hermann Kreyenberg

Cytotherapy· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
Zyrafete Kuçi, Selim Kuçi, Susanne Zircher, Stefanie Koller, Ralf Schubert

Cytotherapy· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
Caroline M Wernicke, Thomas Gp Grunewald, Juenger Hendrik, Selim Kuci, Zyrafete Kuci

Int Arch Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Selim Kuçi, Eva Rettinger, Bernhard Voss, Gerrit Weber, Miriam Stais

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis